<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.huliq.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>B-cell depletion therapy</title>
 <link>http://www.huliq.com/tags/b-cell-depletion-therapy</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>Refractory lupus patients remain stable at long term follow-up</title>
 <link>http://www.huliq.com/24672/refractory-lupus-patients-remain-stable-at-long-term-follow-up</link>
 <description>36% of patients with refractory &lt;strong&gt;systemic lupus erythematosus &lt;/strong&gt;(SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without needing further standard immunosuppressive agents, according to a study presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. </description>
 <comments>http://www.huliq.com/24672/refractory-lupus-patients-remain-stable-at-long-term-follow-up#comments</comments>
 <category domain="http://www.huliq.com/health">Health</category>
 <category domain="http://www.huliq.com/tags/b-cell-depletion-therapy">B-cell depletion therapy</category>
 <category domain="http://www.huliq.com/tags/hyponatriaemia">hyponatriaemia</category>
 <category domain="http://www.huliq.com/tags/lupus-disease-treatment">lupus disease treatment</category>
 <category domain="http://www.huliq.com/tags/systemic-lupus-erythematosus">Systemic lupus erythematosus</category>
 <pubDate>Thu, 14 Jun 2007 11:31:46 -0500</pubDate>
 <dc:creator>harminka</dc:creator>
 <guid isPermaLink="false">24672 at http://www.huliq.com</guid>
</item>
</channel>
</rss>
